Navigation Links
Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
Date:8/28/2007

Phase I/II Clinical Studies Set To Begin By Early 2008

WOODRIDGE, Ill., Aug. 28 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to its oncology product, ALS-357, for the topical treatment of metastatic melanoma. Melanoma is estimated to be the sixth most common cancer among new cases of cancer in the United States and accounts for about 4% of all skin cancers but causes about 79% of skin cancer deaths.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO)

ALS-357 is a novel drug entering phase I/II clinical development that has demonstrated potent anti-tumor activity against malignant melanoma. ALS-357 has shown promise in both in vitro and in vivo preclinical studies. Rapid tumor regression has been shown in a mouse model and no observable toxicity was seen even at high doses. ALS-357 operates by inducing apoptosis, or programmed cell death, in the tumor cells.

Michael T. Flavin, Ph.D., chief executive officer of Advanced Life Sciences, commented on the notice of designation saying that "We are pleased with the orphan drug designation for ALS-357 as a topical treatment for metastatic melanoma. With a unique mechanism of action and a favorable preclinical safety profile, we believe ALS-357 can become an important oncology treatment in the future. Our Phase I/II study, which is currently slated to commence in early 2008, will help determine whether the promising results we observed in preclinical studies can be translated into the human population. The Or
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
10. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Ind. , March 30, 2015  Zimmer ... today that the European Commission ("EC") has conditionally ...  The EC,s clearance is conditioned upon Zimmer entering ... certain assets comprising the remedy package previously submitted ... such agreements in the near term.  As previously ...
(Date:3/30/2015)... 25, 2015 Research and Markets ( ... "Global Healthcare Cloud Computing Market 2015-2019" report to ... Healthcare Cloud Computing market to grow at a CAGR ... Increased adoption of IT in healthcare has led to ... the Global Healthcare industry. Though there are significant challenges ...
(Date:3/30/2015)... 2015  The future of cancer care with ... analytics; new, more precise methods for delivering stereotactic ... techniques.  Some 150 researchers from leading clinics around ... a symposium on research funded by Varian Medical ... "Researchers are developing, testing, and validating new innovations, ...
Breaking Medicine Technology:Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 2Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 3Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 4Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 5Global Healthcare Cloud Computing Market 2015-2019 with Agfa, CareCloud, Carestream Health, Cisco, ClearData Networks, Dell, GE & Merge Healthcare Dominating 2Radiation Oncology Researchers Glimpse the Future of Cancer Care 2Radiation Oncology Researchers Glimpse the Future of Cancer Care 3Radiation Oncology Researchers Glimpse the Future of Cancer Care 4Radiation Oncology Researchers Glimpse the Future of Cancer Care 5Radiation Oncology Researchers Glimpse the Future of Cancer Care 6
... Md., Aug. 30, 2011 Eurotech , a ... announces they have been selected to supply embedded ... that specializes in diagnostics solutions.  The value of the ... http://photos.prnewswire.com/prnh/20090226/PH75840LOGO) The Eurotech Sphere II will allow ...
... Pa., Aug. 30, 2011 Unilife Corporation ("Unilife" or ... today announced the development of a unique proprietary range ... patients outside of healthcare facilities. Developed for ... are compact in size and enable patients to inject ...
Cached Medicine Technology:Eurotech Awarded 1.5M USD Contract to Supply Embedded Computers for Medical Application 2Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs 2Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs 3Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs 4Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs 5
(Date:3/30/2015)... (PRWEB) March 30, 2015 “ iCareTech ” ... Report, which takes a look at the latest and coolest ... NewsWatch special reporter and technology expert, conducted the review and ... band that’s dedicated to the medical and health fields. , ... of conversation over the past couple of years. Well, at ...
(Date:3/30/2015)... 30, 2015 According to a recently ... hernia repair market will continue to dominate the European ... primarily due to increasing numbers of ventral hernias, and ... , “The significantly large market share represented by ventral ... ASP. We’re seeing a growing use of expensive biologics,” ...
(Date:3/30/2015)... 30, 2015 Follow us on ... to develop and establish chronic pain rehabilitation centers are ... the market is poised to benefit from the rise ... the increase in chronic health conditions such as Cancer, ... among others. While conventional treatment for pain management is ...
(Date:3/30/2015)... March 30, 2015 Dr. Shahdad ... Invisalign. Eligible patients will receive $200 off their Invisalign ... particularly interested in wearing a mouthful of metal. Invisalign ... use of traditional braces is effective for straightening teeth ... already concerned with their oral appearance. The Invisalign system ...
(Date:3/30/2015)... Slidezilla, an app from the makers ... that innovates the fun and simplicity of photo slideshows. ... photo slideshows and then instantly share them across their ... wanted to create a slideshow app where users can ... fun options to personalize them. You can choose your ...
Breaking Medicine News(10 mins):Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2
... and Emcure Pharmaceuticals Ltd, a Pune-based company have jointly ... of hypertension. Announcing this at a press conference here ... Satish Mehta said the chirally pure S-Amlodipine, a product ... for the patients suffering from hypertension. ,Stating ...
... that has receive only a little scientific interest and virtually ... and respiratory health. A study of over 2,000 children ... issue. The study appeared in the January 15, 2002 ... and potassium intakes were associated with lower lung function. ...
... research from Australian company has finalized development of ... the guesswork out of diagnosing melanomas, the third ... director of Polartechnics said that in terms of ... specialists.// ,Image analysis and computer-aided diagnostic software ...
... red wine drinkers have increased HDL cholesterol, commonly referred ... light on why red wine is believed to be ... cholesterol levels between 40 men who drink every now ... who are heavy drinkers. As alcohol consumption shot up, ...
... University of Michigan, made a new study which ... head and neck surgery. Ann Arbor say leeches are an ... surgery// to remove cancer in and around the head and ... say about 15 percent of patients develop obstructions that cannot ...
... is able to differentiate those who will get Alzheimer's disease ... of older people - so we can expect an increase ... are now available and they seem to work best if ... ,Researchers at the University of Toronto have been ...
Cached Medicine News:Health News:Latest device for identifying Melanomas 2
... 16 electrodes with ball joint, and flexible wire ... assembly, with 16 female support for ball joint of ... individual electrodes with flexible wire and carbon tip. ... skull. Mounting post. Key to ...
... synergy T-EP Developed in collaboration with ... and an exceptionally high standard of ... Multimedia technology and design expertise to ... 2, 5 or 10-channel Medelec Synergy ...
Neuropack MEB-2200 evoked potential/EMG measuring system is user friendly Windows NT, Pentium III PC-based EP/EMG measuring system....
Sierra II power & efficiency plus. Sierra II report generator with automatic sentence generation creates the one-minute report. Complete 2/4 channel EMG/NCV/EP....
Medicine Products: